What should be given to a patient with an activated partial thromboplastin time of approximately 38 seconds and an international normalized ratio of 1.33?

Management of Mildly Elevated Coagulation Parameters

These coagulation values (aPTT 37.8 seconds, INR 1.33) are minimally elevated and typically do not require immediate reversal or specific treatment in most clinical contexts. 1

Clinical Context Assessment

The appropriate management depends entirely on the clinical scenario:

If Patient is Bleeding or Requires Urgent Surgery

For active bleeding with these values:

• Fresh frozen plasma (FFP) is indicated when INR >2.0 times normal or aPTT >1.5 times control in the setting of active hemorrhage 1
• Your patient's values (INR 1.33, aPTT ~37.8 sec) fall below these thresholds and would not typically warrant blood product transfusion 1

For urgent surgery:

• Prothrombin complex concentrate (PCC) is reserved for urgent warfarin reversal when INR is significantly elevated (typically ≥2.0) 2
• At an INR of 1.33, PCC administration is not indicated 2

If Patient is on Anticoagulation Therapy

For warfarin over-anticoagulation:

• The therapeutic INR range for most indications is 2.0-3.0 1, 3
• An INR of 1.33 represents sub-therapeutic anticoagulation, not over-anticoagulation 1, 3
• No reversal agent is needed; instead, consider increasing the warfarin dose if therapeutic anticoagulation is the goal 1, 3

For heparin monitoring:

• Therapeutic aPTT range for unfractionated heparin is typically 1.5-2.5 times control (approximately 60-80 seconds for most reagents) 1
• An aPTT of 37.8 seconds is below therapeutic range for heparin therapy 4, 5
• If on heparin, the dose should be increased, not reversed 1

If Patient Has No Known Anticoagulation

For isolated mild elevations without bleeding:

• An aPTT ratio of approximately 1.2-1.3 (assuming normal control ~30 seconds) may represent normal variation or mild factor deficiency 6, 5
• An INR of 1.33 is only minimally elevated above normal (1.0) and may not be clinically significant 6, 7
• No treatment is required unless there is active bleeding or urgent surgery planned 5

Common Pitfalls to Avoid

Do not reflexively give vitamin K, FFP, or PCC for these values:

• These coagulation parameters do not meet criteria for coagulopathy requiring reversal 1
• Vitamin K is indicated for INR >7.0 in asymptomatic patients or lower values with bleeding 8
• FFP transfusion criteria include INR >2 times normal or aPTT >1.5 times control in bleeding patients 1

Consider laboratory variability:

• Different coagulation analyzers can produce significantly different aPTT results (up to 20 seconds difference) 7, 4
• INR with local mean normal PT shows better agreement between instruments than raw PT values 7

Specific Recommendations by Clinical Scenario

If asymptomatic with no planned procedures:

• No intervention required 5
• Repeat testing if clinically indicated 5

If on warfarin for therapeutic anticoagulation:

• Increase warfarin dose to achieve target INR 2.0-3.0 1, 3

If on heparin infusion:

• Increase heparin infusion rate to achieve therapeutic aPTT (typically 60-80 seconds) 1

If bleeding with these values:

• Address surgical bleeding source first 1
• These coagulation values alone do not explain significant bleeding 1